Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Stem cells

August 1, 2022 Drug delivery / Pharma applications

Cyclodextrin in tissue engineering

The field of tissue engineering continues to advance, sometimes in exponential leaps forward, but also sometimes at a rate that

Continue reading

August 23, 2021 CD as API / Pharma applications

HPBCD reduced the disease phenotypes in Mucopolysaccharidosis type IIIB induced pluripotent-stem-cell-derived neuronal cells

Mucopolysaccharidoses (MPSs) are a group of lysosomal storage diseases caused by inherited deficiencies of eleven enzymes involved in the degradation

Continue reading

April 17, 2020 Events / Non-pharma applications / Pharma applications

Global Congress on Biotechnology -ONLINE EVENT

The 24th Global Congress on Biotechnology will be held online during June 15-16, 2020 in London, UK. The conference highlights:

Continue reading

February 21, 2020 Events / Non-pharma applications / Pharma applications

Global Congress on Biotechnology

The 24th Global Congress on Biotechnology will be held during June 15-16, 2020 in London, UK. The conference highlights:  

Continue reading

November 11, 2019 Agriculture / Drug delivery / Environmental / Events / Other industrial use

24th Global Congress on Biotechnology

The 24th Global Congress on Biotechnology to be held in London, UK from February 24-25, 2020 organized by Conference Series

Continue reading

Recent Posts

  • Bacteroides uniformis and its preferred substrate, α-cyclodextrin, enhance endurance exercise performance in mice and human males
  • Waterproof and durable luminescent textiles with HPBCD for marine rescue
  • Small anticancer drug release by light
  • Patent application on reduction of envelope viral particle number in a composition containing cyclodextrin
  • γ-Cyclodextrin/Epigallocatechin-3-gallate Inclusion Complexes as Efficient Antioxidants for Preservation of Shrimp Surimi Products

Tags

alpha-CD antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (35)
  • CD as API (199)
  • CD derivatives (251)
  • Cosmetics and toilettry (21)
  • Drug delivery (416)
  • E-ducation (54)
  • Environmental (76)
  • Events (157)
  • Food (120)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (13)
  • Non-pharma applications (209)
  • Other industrial use (58)
  • Pharma applications (677)
  • Supramolecular systems (25)
  • Uncategorized (41)

Top Posts

  • Lanosterol eye drops for cataract treatment
  • Waterproof and durable luminescent textiles with HPBCD for marine rescue
  • γ-Cyclodextrin/Epigallocatechin-3-gallate Inclusion Complexes as Efficient Antioxidants for Preservation of Shrimp Surimi Products
  • Small anticancer drug release by light
  • New book: Cyclodextrins - new Perspectives
  • Bacteroides uniformis and its preferred substrate, α-cyclodextrin, enhance endurance exercise performance in mice and human males
  • Cyclodextrin Metal-Organic Framework as a Broad-Spectrum Potential Delivery Vehicle for the Gasotransmitters
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease
  • Pilocarpine eye drops (Vuity)
  • Current Overview of Cyclodextrin-Based Nanocarriers for Enhanced Antifungal Delivery

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 521 other subscribers
 

Loading Comments...